NPC patients with high EBV-miR-BART10-3p expression were shown to have a poor prognosis [22], where EBV-miR-BART10-3p might enhance NPC cell migration and invasion, through β-Transducin Repeat Containing E3 Ubiquitin Protein Ligase (BTRC) inhibition [22, 82, 83]. The gene discussed is BTRC; the disease is nasopharyngeal carcinoma.